BAYZF News and Press, Bayer AG Registered Shares From 03/05/24

2024-03-05 07:20:32 ET More on Bayer Bayer: Long-Term Upside After The Dividend Cut Bayer Isn't Dead Seeking Alpha's Quant Rating on Bayer Read the full article on Seeking Alpha For further details see: Bayer will not split into separate units for...

2024-02-25 12:00:00 ET More on AstraZeneca, Bristol-Myers, etc. Eli Lilly: Will It Be The First Ever Trillion-Dollar Drug Company? Eli Lilly: Yes, It Is Too Late To Join The Party Eli Lilly: Very Strong Fundamentals, But Market Is Euphoric Phase 3 data for As...

2024-02-24 01:08:00 ET Summary Even if the U.S. Federal Reserve starts reversing its policy later this year as expected and makes money available a little more cheaply, corporate borrowing expenses will nevertheless keep rising. Companies with better credit ratings did so more eas...

2024-02-21 07:13:01 ET Regeneron ( NASDAQ: REGN ) and Vertex Pharmaceuticals ( NASDAQ: VRTX ) have crossed $100B in market capitalization for the first time, joining two other giants in the biotech industry, Amgen ( AMGN ) and AbbVie ( ABBV ).... Read the full ...

2024-02-20 14:38:36 ET Summary Bayer recently cut its dividend by more than 90%, resulting in a dividend yield of less than 1%. The company's valuation actually rose after the dividend cut, indicating investor approval. Bayer's risks include ongoing litigation related to glyph...

2024-02-20 06:45:21 ET Summary Capital One acquires Discover Financial Services in a stock-based deal valued at $35.3B. Bayer plans to reduce its dividend by 95% to reduce debt. Palo Alto Networks is expected to report strong Q2 earnings. Listen below or on the go on...

2024-02-19 18:08:23 ET More on Bayer, Bayer AG, etc. Bayer Isn't Dead U.S. appeals court refuses to shield Bayer from Roundup lawsuit Bayer slumps after $2.25B jury award on Roundup damages claim Seeking Alpha’s Quant Rating on Bayer Historical...

2024-02-18 11:30:00 ET Summary Broyhill Asset Management is a boutique investment firm guided by a disciplined value orientation. We operate outside of the fray and invest with a rational, objective, long-term perspective. The largest contributors to the portfolio's performance fo...

2024-02-14 08:15:00 ET Summary Markets continued to go higher in early 2024 with the Dow adding 0.4% and the S&P remaining flat in January. Interest rates were kept steady again in a range of 5.25% to 5.5% with the market now projecting fewer hikes this year as the economy rem...

2024-02-11 01:25:00 ET Summary I-Mab Hangzhou will acquire rights to I-Mab’s drug assets in Greater China for $80 M. Anbogen Therapeutics raised $12.5M in a Series A funding round. to advance its two lead drug candidates. Bayer signed a non-binding Letter of Intent to m...